Episode 88: Dr. David Sable on an alarming genetic test & Jorge Conde on the perils of bio-Twitter
Do you trust Google with your health data? Is "Gattaca" an outdated reference? And what's it like to get dunked on?
14 Nov 201925min
Episode 87: Derek Lowe on China's new Alzheimer's drug, blockbuster fish oil, & STAT's birthday
Why hope for China's new Alzheimer's drug turned into skepticism ? Is three a crowd in CAR-T? And what's a Bionomy?
7 Nov 201920min
Episode 86: Drugs that don't work, wearables in the desert, & excess 'innovation'
When should a drug be pulled from shelves? How do you pronounce "HLTH?" And how does Ann Coulter decide what to tweet?
31 Okt 201928min
Episode 85: Every angle on Biogen's shocking Alzheimer's news
What exactly is Biogen doing? When is a press release worth $12 billion? And what should patients make of whiplashing news? We're devoting this entire episode to Biogen's stunning announcement that ad...
24 Okt 201928min
Episode 84: CRISPR with Netflix filmmakers, Pharma's future in China & where VC dollars come from
Should drug companies be free-speech advocates? Is your retirement dependent on CRISPR? And how useful is a glow-in-the-dark dog?
17 Okt 201926min
Episode 83: How biotech VC works w/ health care journalist Maggie Fox, Vioxx and synthetic biology
STAT's Matthew Herper joins us to dig into the history of the infamous pain drug Vioxx and a new effort to bring it back as a rare disease treatment. Then, we discuss how the synthetic biology industr...
10 Okt 201923min
Episode 82: Drug shortages with Dr. Ben Davies, congressional paralysis & biotech's foul mood
Does impeachment have a pharma angle? Who's to blame for drug shortages? And why is Wall Street down on biotech?
3 Okt 201923min
Episode 81: Vaping upheaval, DNA test dynamics, & the future of genome editing
What do we talk about when we talk about "vape"? Are there limits to business of DNA testing? And how hard is it to get yourself CRISPR'd? STAT's Megan Thielking joins the gang to break down a major ...
26 Sep 201926min
